Search

Your search keyword '"Kayani, Irfan"' showing total 16 results
Start Over Author "Kayani, Irfan" Publisher springer science and business media llc
16 results on '"Kayani, Irfan"'

5. Non-small-cell lung cancer resectability: diagnostic value of PET/MR

Author

Fraioli, Francesco, primary, Screaton, Nicholas J., additional, Janes, Samuel M., additional, Win, Thida, additional, Menezes, Leon, additional, Kayani, Irfan, additional, Syed, Rizwan, additional, Zaccagna, Fulvio, additional, O’Meara, Celia, additional, Barnes, Anna, additional, Bomanji, Jamshed B., additional, Punwani, Shonit, additional, and Groves, Ashley M., additional

Published
2014
Full Text
View/download PDF

6. 18F-Fluorodeoxyglucose positron emission tomography pulmonary imaging in idiopathic pulmonary fibrosis is reproducible: implications for future clinical trials

Author

Win, Thida, primary, Lambrou, Tryphon, additional, Hutton, Brian F., additional, Kayani, Irfan, additional, Screaton, Nicholas J., additional, Porter, Joanna C., additional, Maher, Toby M., additional, Endozo, Raymondo, additional, Shortman, Robert I., additional, Lukey, Pauline, additional, and Groves, Ashley M., additional

Published
2011
Full Text
View/download PDF

11. Cardiac 82rubidium PET/CT: initial European experience

Author

Groves, Ashley M., primary, Speechly-Dick, Marie-Elsya, additional, Dickson, John C., additional, Kayani, Irfan, additional, Endozo, Raymondo, additional, Blanchard, Patty, additional, Shastry, Manu, additional, Prvulovich, Elizabeth, additional, Waddington, Wendy A., additional, Ben-Haim, Simona, additional, Bomanji, Jamshed B., additional, McEwan, Jean R., additional, and Ell, Peter J., additional

Published
2007
Full Text
View/download PDF

14. Oral contrast medium in PET/CT: should you or shouldn’t you?

Author

Groves, Ashley M., primary, Kayani, Irfan, additional, Dickson, John C., additional, Townsend, Caroline, additional, Croasdale, Ian, additional, Syed, Rizwan, additional, Nagabushan, Nagesh, additional, Hain, Sharon F., additional, Ell, Peter J., additional, and Bomanji, Jamshed B., additional

Published
2005
Full Text
View/download PDF

15. Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC)

Author

Luigi Gianolli, Pierpaolo Alongi, Maria Picchio, Irfan Kayani, Jamshed Bomanji, Elena Incerti, Federico Fallanca, Fallanca, Federico, Alongi, Pierpaolo, Incerti, Elena, Gianolli, Luigi, Picchio, Maria, Kayani, Irfan, and Bomanji, Jamshed

Subjects
Male, Radiology, Nuclear Medicine and Imaging, Lymphoma, Diagnostic accuracy, International Harmonization Project Criteria, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Retrospective Studie, Positron Emission Tomography Computed Tomography, Outcome Assessment, Health Care, International harmonization, End of therapy, Child, Non-Hodgkin lymphoma, Aged, 80 and over, 18F-FDG PET/CT, Hazard ratio, General Medicine, Middle Aged, Survival Rate, Italy, 030220 oncology & carcinogenesis, Practice Guidelines as Topic, Radiopharmaceutical, Female, Fdg pet ct, Radiology, Human, Adult, medicine.medical_specialty, Adolescent, Restaging, Deauville Criteria, Reproducibility of Result, Sensitivity and Specificity, Outcome Assessment (Health Care), Young Adult, 03 medical and health sciences, Fluorodeoxyglucose F18, medicine, Humans, Radiology, Nuclear Medicine and imaging, Survival rate, Retrospective Studies, business.industry, Proportional hazards model, Reproducibility of Results, Retrospective cohort study, medicine.disease, United Kingdom, Radiopharmaceuticals, Nuclear medicine, business, Hodgkin lymphoma
Abstract

Purpose: To evaluate the accuracy and prognostic value of FDG PET/CT for response assessment after treatment in patients with Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) when using the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC). Methods: This retrospective study included 101 patients (35 HL, 66 NHL) who underwent early restaging FDG PET/CT after treatment. Scans were evaluated using the IHPC and DC. Two thresholds of positivity for the DC were used: a score of at least 3 (DC3, i.e. scores 3 – 5) and a score of at least 4 (DC4, i.e. a score of 4 or 5). Accuracy was assessed using conventional diagnostic procedures, multidisciplinary team case notes, further PET/CT scans and/or follow-up. Progression-free survival and overall survival were computed using the Kaplan-Meier method. The Cox proportional hazards model was used to identify predictors of outcome. Results: Sensitivity, specificity, positive predictive value, negative predictive value and accuracy of FDG PET/CT for early restaging were, respectively, 92 %, 87 %, 74 %, 92 % and 86 % using DC4, 97 %, 76 %, 64 %, 98 % and 84 % using DC3, and 97 %, 67 %, 57 %, 98 % and 76 % using the IHPC. FDG PET/CT positivity was associated with a worse cumulative survival rate over a 2-year period when using DC4 in comparison with the IHPC (20 % vs. 49 %; p < 0.05) and DC3 (47 %; p < 0.05). Cox regression analysis showed different risks of progression in patients positive on FDG PET/CT using the IHPC, DC3 and DC4 (hazard ratios 1.57, 0.7 and 3.2, respectively). Conclusion: FDG PET/CT using DC4 showed higher diagnostic accuracy for HL and NHL than FDG PET/CT using either the IHPC or DC3, indicating its value in predicting clinical outcome after treatment.

Published
2016
Full Text
View/download PDF

16. Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma

Author

Elena Incerti, Pierpaolo Alongi, Jamshed Bomanji, Federico Fallanca, Luigi Gianolli, Maria Picchio, Irfan Kayani, Fallanca, Federico, Alongi, Pierpaolo, Incerti, Elena, Gianolli, Luigi, Picchio, Maria, Kayani, Irfan, and Bomanji, Jamshed B.

Subjects
Radiology, Nuclear Medicine and Imaging, Lymphoma, Treatment outcome, Reproducibility of Result, Sensitivity and Specificity, 030218 nuclear medicine & medical imaging, Outcome Assessment (Health Care), 03 medical and health sciences, 0302 clinical medicine, Text mining, Fluorodeoxyglucose F18, Outcome Assessment, Health Care, medicine, Humans, Radiology, Nuclear Medicine and imaging, medicine.diagnostic_test, business.industry, Reproducibility of Results, General Medicine, medicine.disease, Predictive value, Treatment Outcome, Positron emission tomography, Positron-Emission Tomography, 030220 oncology & carcinogenesis, Radiopharmaceutical, Radiopharmaceuticals, business, Nuclear medicine, Human
Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results